ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2022 American Transplant Congress

    Place Based Risk for Early Rejection in Lung Transplant

    W. M. Tsuang1, X. Wang2, J. Curtis3

    1Respiratory Institute, Cleveland Clinic, Cleveland, OH, 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 3Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH

    *Purpose: Within 5 years after lung transplant (LT), half of recipients have lost 20% or more of lung function. Despite a consistent link between social…
  • 2022 American Transplant Congress

    Molecular Associations in Kidney Transplant Biopsies in the Trifecta Study Indicate That at Least Three Distinct Processes Release Dd-cfDNA: ABMR, TCMR, and Injury

    P. F. Halloran1, J. Reeve1, K. S. Madill-Thomsen1, Z. Demko2, A. Prewett2, P. Billings2, .. and the Trifecta Investigators3

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2Natera Inc., San Carlos, CA, 3., ., AB, Canada

    *Purpose: In the Trifecta study (ClinicalTrials.gov # NCT04239703 53), elevated plasma dd-cfDNA is associated with molecular rejection in kidney transplant indication biopsies, particularly active ABMR…
  • 2022 American Transplant Congress

    Upregulation of Innate Immune Pathways is Associated with Increased Rejection in HIV-Infected Kidney Transplant Recipients

    A. Zarinsefat1, Y. Kelly1, D. Dobi1, G. Szabo1, Z. Laszik1, P. Stock1, H. Braun2

    1UC San Francisco, San Francisco, CA, 2CA

    *Purpose: Although kidney transplantation (KT) has become the standard of care for HIV+ patients with renal failure, early experiences revealed high acute rejection (AR) rates.…
  • 2022 American Transplant Congress

    Flow Cytometric Pattern of γδ Tcr Expression Identifies Outcomes in Kidney Transplantation

    S. Sur, S. Pineda, M. Sirota, M. Sarwal

    UCSF, San Francisco, CA

    *Purpose: The main challenge with kidney transplantation is the possibility of rejection, classified into two types, antibody-mediated rejection (ABMR) and T cell-mediated rejection (TCMR). The…
  • 2022 American Transplant Congress

    Evaluation of Genotype Based Clustering Method of Single-Cell RNA-Sequencing Data from Human Kidney Allograft Biopsies

    G. Thareja1, A. Belkadi1, S. Rahim2, H. Yang2, F. B. Mueller2, K. Suhre1, M. Suthanthiran2, T. Muthukumar2

    1Weill Cornell Medicine, Doha, Qatar, 2Weill Cornell Medicine, New York, NY

    *Purpose: Single-cell RNA sequencing (scRNA-seq) characterizes expression profiles of individual cells, providing novel insights into new cell types or new cell states that were not…
  • 2022 American Transplant Congress

    Immune Cell Phenotype of Acute Rejection of Pancreas Allografts by RNA Sequencing Analysis

    C. Hughes, H. Yang, C. Snopkowski, C. Li, D. M. Dadhania, S. Sultan, C. Hartono, M. Suthanthiran, S. V. Seshan, T. Muthukumar

    Weill Cornell Medicine, New York, NY

    *Purpose: Long term survival of pancreas allografts are inferior to kidney allografts. Molecular mechanisms underpinning pancreas allograft rejection and failure have not been explored in…
  • 2022 American Transplant Congress

    Microvascular Inflammation in Kidney Transplant Biopsies in the Absence of HLA-DSA Displays Intense Cytotoxic T-cell and NK Cell but Not Plasma Cell Infiltration

    A. Buxeda1, L. Llinàs-Mallol1, J. Gimeno2, D. Redondo-Pachón1, C. Arias-Cabrales1, C. Burballa1, A. Puche2, M. Pérez-Sáez1, J. Pascual3, M. Crespo1

    1Nephrology Department, Hospital del Mar, Institute Mar for Medical Research (IMIM), Barcelona, Spain, 2Pathology Department, Hospital del Mar, Institute Mar for Medical Research (IMIM), Barcelona, Spain, 3Nephrology Department, Hospital Universitario 12 de Octubre. Institute Mar for Medical Research (IMIM), Madrid, Spain

    *Purpose: Microvascular inflammation (MVI) without evidence of HLA-donor-specific antibodies (HLA-DSA) or C4d+ deposition remains an enigmatic phenotype, which cannot be classified as antibody-mediated rejection (ABMR)…
  • 2022 American Transplant Congress

    Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection

    R. Gohh1, J. Klein2, M. Jagadeesan3, V. Rao4, M. Weir5, H. Gilligan6, G. Shekhtman7, N. Agrawal8, Y. Fu9, E. Akalin10

    1Alpert School of Medicine, Brown University, Providence, RI, 2University of Kansas Medical Center, Kansas City, KS, 3George Washington School of Medicine, Washington, DC, 4Medical University of South Carolina, Charleston, SC, 5University of Maryland, Baltimore, MD, 6Massachusetts General Hospital, Boston, MA, 7CareDx Inc., Brisbane, CA, 8CareDx Inc, Brisbane, CA, 9CareDx, Brisbane, CA, 10Montefiore Medical Center, Bronx, NY

    *Purpose: Surveillance of dd-cfDNA after therapy for rejection represents a promising strategy for monitoring post-treatment response. We assessed post-rejection kinetics of dd-cfDNA among kidney transplant…
  • 2022 American Transplant Congress

    The Successful Use of De Novo Belatacept with Reduced Dose Tacrolimus to Mitigate the Risks of Delayed Graft Function in Kidney Transplantation

    E. Siskind1, J. Splinter1, C. Taing1, A. Adekile2, S. Njim1, S. Shah1, R. Plews3, D. Conti4, S. Patel2

    1Center for Transplantation, University Medical Center of Southern Nevada, Las Vegas, NV, 2University Medical Center of Southern Nevada, Las Vegas, NV, 3Center for Transplantation, Albany Medical Center, Albany, NY, 4Albany Medical Center, Albany, NY

    *Purpose: The new kidney allocation system has caused increased organ travel times and therefore increased cold ischemia time. Furthermore, the change in the priority to…
  • 2022 American Transplant Congress

    Kidney Allograft Injury is Reflected in the DNA Cargo of Urinary Extracellular Vesicles

    I. Sedej1, M. Štalekar2, M. Tušek Žnidarič2, K. Goričar3, N. Kojc4, P. Kogovšek2, V. Dolžan3, M. Lenassi3, M. Arnol1

    1Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 2Department of Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, Slovenia, 3Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, 4Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

    *Purpose: Following cell injury, donor-derived cell-free DNA (ddcfDNA) is increased in the urine of kidney transplant recipients. DNA containing urinary extracellular vesicles (uEVs) are relevant…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences